← Back
Data updated: Mar 10, 2026
SHILPA MEDICARE LTD
Oncology
SHILPA MEDICARE LTD is a pharmaceutical company focused on Oncology. Key products include AZACITIDINE.
2016
Since
3
Drugs
-
Trials
47
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
AZACITIDINE 2025-07-01
Labeling
AZACITIDINE 2025-07-01
Labeling
AZACITIDINE 2025-05-20
AZACITIDINE 2025-04-29
Labeling
AZACITIDINE 2025-04-29
Labeling
AZACITIDINE 2025-01-24
Labeling
DIMETHYL FUMARATE 2025-01-22
Labeling
DIMETHYL FUMARATE 2025-01-14
Labeling
DIMETHYL FUMARATE 2025-01-06
AZACITIDINE 2024-12-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2016-09-29
- Latest
- 2024-12-23
- Applications
- 5
FDA Sponsor Names
SHILPA MEDICARE LTDSHILPA MEDICARE